Body Surface Isopotential Mapping of Permanent Cardiac Pacemaker Spike Amplitudes: A Noninvasive Method for Detecting and Localizing Insulation Failure

Cardiac pacing systems produce cardiac contractions by delivering electrical charges to the myocardium. Reliable cardiac pacing, and the longevity of pacemakers depends on the absence of electrical leaks. Electrical leaks often do not cause symptoms and if suspected, there are few methods which are able to identify their location and none suited to small or intermittent leaks. We surface mapped the pacemaker spike amplitudes over the pockets of 29 patients with unipolar pacemakers, several of which had suspected pacemaker leaks. For each patient, pacer voltage spikes were recorded with an optical ECG recorder from sixty-three positions on the skin over the pacemaker. The spike voltages were interpolated with a 2-D Fourier transform, contoured, and plotted by a computer. Electrical leaks were readily detected and their positions indicated by the resulting maps. The operative findings confirmed the map guided prediction in all six patients sent for pacemaker revision. Pacemaker spike amplitude surface mapping detects and locates pacing system insulation failures.     

Myopotential Inhibition of Unipolar QRS-inhibited (VVI) Pacemakers, Assessed by Ambulatory Holter Monitoring of the Electrocardiogram

Seventy-four patients with unipolar QRS-inhibited pacemakers (VVI) were Holter monitored to assess the occurrence of pacemaker inhibition caused by skeletal muscle potentials during daily activities. Fifty patients had high-grade atrioventricular block and 24 had sinoatrial disease. Chest wall stimulation prior to monitoring revealed asystole of > 4 seconds duration in 22 patients, and ventricular rates between 25 and 56 beats per minute in 52 patients. Fifty-one patients (69%) had one or more episodes of pacemaker inhibition from myopotentials. Inhibition occurred in all types of pacemakers studies, but was most frequent and of longest duration in patients with Siemens-Elema 207/70 (13/14 patients), Cordis Omni-Stanicor (6/7 patients), CPI Microlith (5/6 patients), and Medtronic 5945 (8/10 patients). This was not unexpected considering the filter characteristics of the pacemakers. Nine patients (12%) presented symptoms which might be ascribed to pacemaker inhibition. The longest asystole observed was 3.2 s. Seven patients had pacemakers spikes falling on or near T-waves of spontaneous heart beats because their pacemakers had been rendered refractory by myopotentials. No serious arrhythmias were seen during episodes of pacemaker inhibition or interference. More emphasis should be put on the improvement of filter characteristics of unipolar VVI-pacemakers. Pacemaker patients with symptoms of myopotential inhibition should be equipped with either a bipolar or ventricular triggered (VVT) pacemaker or with a sensitivity and/or pacing mode programmable pacemaker.     

Pacemaker Headaches

A symptom complex (pacemaker syndrome) consisting of hypotension, dizziness, or near-syncope in patients with functioning ventricular pacemakers has been previously described. Whereas, the effects of synchronized ventriculo-atrial contraction on forward systemic circulation are known, the effects of increased venous dynamics on systemic function are not known. We describe a patient who developed severe headaches during periods of ventricular pacing with retrograde ventriculo-atrial conduction. These headaches occurred in the absence of symptoms of Pacemaker syndrome or of changes in systemic blood pressure. We believe that the headaches were caused by alterations in intracranial pressure from exaggerated pulsatile venous dynamics. Conversion of the pacing system from VVI to AV sequential pacing completely relieved the headaches.     

The Clinical Incidence and Significance of Myopotential Sensing with Unipolar Pacemakers

Myopotential oversensing by unipolar pulse generators can cause patient symptoms ranging from dizziness and syncope to ventricular tachycardia. Seventy-seven patients with implanted unipolar pacemakers from three manufacturers participated in isometric and reach exercises to evaluate their pacemakers susceptibility to myopotentials. Myopotential inhibition occurred in 47% of the patients performing the reach maneuver. Testing revealed a wide difference in level of susceptibility to myopotentials between pacemakers of different manufacture (a low of 33% inhibition for the least susceptible to a high of 78% inhibition for the most susceptible during the reach maneuver). The normal pacing interval was extended by myopotential oversensing for each manufacturer's model within a range of 0.3–3.9 seconds. Pulse generators incorporating additional automatically-adjusting threshold and reversion circuits in the sense amplifier along with standard bandpass filtering exhibited: a) two-to-three times less susceptibility to myopotentials; and b) a 75% reduction in the maximum pacing interval extension as compared with pacemakers with bandpass filtering alone. The effectiveness of insulative coating in reducing myopotential inhibition was substantiated as coated pulse generators had a 22% lower incidence of muscle sensing than those than were uncoated. Six out of seven patients tested had symptoms during Holter monitoring which correlated with pacemaker myopotential inhibition. Selecting pulse generators with improved sensing amplifiers, clinical testing of patients with unipolar pacemakers using the reach method, and reprogramming of sensitivity will significantly reduce the incidence of myopotential inhibition.     

Electronic pacemakers

The number of patients who have cardiac pacemakers has increased markedly over the past few decades since the technology was first introduced in the 1950s. Advances in technology, expanding indications, and the aging of the population ensure that clinicians will encounter patients with cardiac pacemakers on a regular basis. This article summarizes the electrocardiographic manifestations of the normally functioning permanent cardiac pacemaker and abnormalities associated with pacemaker malfunction.     

Diagnosis of Paroxysmal Atrial Fibrillation in Patients with Implanted Pacemakers: Relationship to Symptoms and Other Variables

Background: Atrial fibrillation (AF) is not always accompanied by clear-cut symptoms and symptoms suggestive of AF may not correspond to a genuine AF episode. The study prospectively evaluated the burden of asymptomatic AF episodes in pacemaker patients (for sick sinus syndrome) with a history of documented paroxysmal AF.
Methods: Consecutive patients were enrolled and implanted with dual-chamber pacemakers equipped with diagnostic features for AF monitoring. Each patient was instructed about typical AF symptoms and was asked to keep a detailed log of symptoms. Stored pacemaker data were analyzed using only AF episodes >30 s.
Results: The mean follow-up was 16 ± 6 months and 102 patients were enrolled (73 ± 7 years, 59 M). Thirteen patients (13%) dropped out with the development of permanent AF and their data were discarded. Twenty-three patients (26%) without device-stored AF episodes all reported at least one annotated AF episode. There were 1,245 device-stored AF episodes in 66 (74%) out of 89 patients. Patients reported 1,141 episodes of AF-related symptoms. Only 240 (21%) corresponded to a genuine device-stored AF event. The sensitivity and positive predictive value of symptoms to detect AF were respectively 19% and 21%. Episode duration, rate increase at the onset of the arrhythmia, heart disease, or antiarrhythmic drug therapy showed no statistically significant differences comparing symptomatic and asymptomatic episodes.
Conclusions: Many pacemaker patients with paroxysmal AF can develop AF-like symptoms in the absence of device-stored AF. AF-related symptoms have low sensitivity and low positive predictive value in patients with permanent pacemakers.     

Unexpected loss of bipolar lead function associated with lead connection design in dual chamber pacemakers

Unexpected loss of bipolar pacing function can occur in Guidant VIGOR dual chamber pacemakers with QC2 (Quick Connect) headers. In a retrospective review of 305 implanted patients, 23 exhibited unexpected loss of bipolar pacing lead function from < 1 to 51 months postimplant. Atrial lead problems were seen in 17 patients and ventricular lead problems in 6 (P < 0.05 atrial vs ventricular). Significant symptoms developed in six patients including two with syncope as a result of noncapture. No significant change in bipolar sensing function was seen. Reprogramming devices to the unipolar mode restored appropriate pacing thresholds and lead impedance. The changes in bipolar lead function are likely caused by failure of the QC2 header lead connection system over time.     

Diastolic Mitral Regurgitation in Patients with First-Degree Atrioventricular Block

Diastolic mitral regurgitation has been observed in patients with DDD pacemakers when the atrioventricular (AV) delay was prolonged. However, diastolic mitral regurgitation associated with first-degree AV block has not been fully studied. We examined transmitral blood flow in 24 patients with first-degree AV block and normal cardiac function (ages 35.3 ± 17.4 years), and in nine patients with DDD pacemakers and normal cardiac function (ages 73.1 ± 8.1 years), using pulsed Doppler echocardiography. Diastolic mitral regurgitation was observed in 19 of 24 patients with first-degree AV block. Although PQ interval was shortened from 0.32 ± 0.06 to 0.20 ± 0.05 seconds (P < 0.01) after 1 mg atropine sulfate IV, the interval between P wave (ECG) and the beginning of diastolic mitral regurgitation did not change, while the duration of diastolic mitral regurgitation was shortened from 0.15 ± 0.03 to 0.05 ± 0.03 seconds (P < 0.01). There was a significant correlation between changes in PQ interval and changes in the duration of diastolic mitral regurgifation (r = 0.92, P < 0.001). Although cardiac output (3.9 ± 0.05 L/min) and pulmonary capillary wedge pressure (5.1 ± 1.5 mmHg) were normal in all patients with pacemakers, diastolic mitral regurgitation was observed when the AV delay was prolonged. The critical PQ interval for the appearance of diastolic mitral regurgitation was 0.23 ± 0.01 seconds. In patients with prolonged PQ intervals, delayed ventricular contraction following atrial contraction may be associated with mitral regurgitation in the presence of a reversed AV pressure gradient. The results of this study suggest that diastolic mitral regurgitation occurs not only in patients with DDD pacemakers, but also with AAIR pacemakers when the PQ interval is prolonged. The occurrence of diastolic mitral regurgitation is associated with the pacing mode or the setting of AV delay.     

Physiological Benefits of a Pacemaker with Dual Chamber Pacing at Low Heart Rates and Single Chamber Rate Responsive Pacing During Exercise

Dual chamber rate responsive pacing may be an ideal mode but may result in high current drain and premature battery depletion. To minimize battery drain during exercise, this study compared a combination pacing mode of IDDD and ventricular rate responsive pacing (WIR). Nine patients were studied who had complete heart block, sinus rhythm, DDD pacemakers, and a reduced mean left ventricular ejection fraction of 44%. Patients were exercised in DDD, WIR, and a combination of DDD at low heart rates and WIR at mean heart rates over 89 bpm. Blood pressure, heart rate, exercise duration, work rate, oxygen uptake, anaerobic threshold, and oxygen pulse were measured. There was no difference in symptoms or in mean cardiopulmonary function indices including exercise duration 10.7. 10.3. 10.3 minutes; heart rate 127. 133. 136 bpm; oxygen uptake 1.4. 1.5. 1.5 L/minute; or anaerobic threshold 5.6, 5.5, 5.7 minutes (p > 0.05) in any mode. A pacemaker that provides atrioventricular synchrony at low heart rates with ventricular rate responsiveness at high heart rates may be an alternative mode for some patients.     

DDIR Versus VVIR Pacing in Patients with Paroxysmal Atrial Tachyarrhythmias

Patients with sinus node dysfunction (SND) in particular those with tachycardia-bradycardia syndrome and patients undergoing atrioventricular nodal ablation procedures for refractory paroxysmal atrial tachyarrhythmias (PAT), are candidates for single chamber (VVIR mode) or dual chamber rate responsive (DDIR mode) systems. To evaluate the benefits and disadvantages of each pacing mode we retrospectively analyzed 33 patients with a history of frequent PAT who received a VVIR (22 patients); or a DDDR pacemaker (11 patients) programmed to the DDIR mode. The mean follow-up time was 25 and 18 months, respectively. Preimplant left atrial diameter was significantly smaller in the DDIR group. Chronic atrial fibrillation developed in 54% of the VVIR patients and 27% of the DDIR group, but this difference was not significant. Complications of patients with VVIR pacemakers included new mitral and tricuspid insufficiency, stroke, pacemaker inlolerance and aggravated congestive heart failure. Patients with DDIR pacemakers had a lower incidence of symptoms and complications. However, this group received more antiarrhythmic medication, required a closer follow-up, and their pacemakers needed frequent reprogramming. Our findings suggest that VVIR is a poor choice for patients with SND, congestive heart failure, and PAT, and that DDIR may be an acceptable alternative.     

Pacemaker stored electrograms: teaching us what is really going on in our patients

Stored electrograms (EGMs), well-known diagnostic tools in implantable cardioverter defibrillators, have now been incorporated in pacemakers as well, thereby increasing their diagnostic capabilities. The clinician can detect and diagnose patient arrhythmias with EGMs and directly validate diagnostic data stored by the devices. The appropriateness of detection algorithms can also be judged. Initial experiences with pacemaker EGMs reveals their potential to detect and diagnose sensing or detection algorithm problems. These so-called "false-positive" EGMs help to optimize pacemaker programming. Date and time stamp can correlate an event to patient symptoms. Recent advances, like onset recordings and marker annotation, have further increased the effectiveness of stored EGMs. The use of patient-triggered magnet-stored EGMs facilitates diagnostic workups in symptomatic pacemaker patients and reveals nondevice related symptoms in a considerable number of cases. Stored EGMs in pacemakers will soon be a standard diagnostic tool that can illustrate what is really going on in our patients.     

Study of Pacemaker and Implantable Cardioverter Defibrillator Triggering by Electronic Article Surveillance Devices (SPICED TEAS)

The magnetic fields emitted by electronic article surveillance (EAS) systems (shoplifting gates) are a source of interference for implanted medical devices. In the Study of Pacemaker and Implantable Cardioverter Defibrillator Triggering by Electronic Article Surveillance Devices (SPICED TEAS), 25 adult volunteers with ICDs and 50 with pacemakers were exposed to the fields of six different EAS systems. These EAS systems used three modes of operation: magnetic audio frequency, swept radio frequency, and acoustomagnetic technology. No ICD exhibited interference mimicking sensing of tachyarrhythmias with any EAS system. Pacemakers interacted variably, depending on the type of EAS system. Swept radiofrequency systems produced no interaction with any implanted medical device. One magnetic audio frequency system interacted with 2 of 50 pacemakers. The acoustomagnetic system interacted with 48 of 50 pacemakers. Interactions included asynchronous pacing, atrial oversensing (producing "EAS induced tachycardia" in the ventricle), ventricular oversensing (with pacemaker inhibition), and paced beats resulting from the direct induction of current in the pacemaker ("EAS induced pacing"). These interactions produced symptoms in some patients ( palpitations, presyncopel only while patients were in the EAS field. No pacemaker was reprogrammed. We conclude that high energy, pulsed low frequency EAS systems such as acoustomagnetic systems interfere with most pacemakers. Pacemaker patients should be advised to minimize exposure to the fields of such systems to prevent the possibility of serious clinical events.     

Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study

The confirmation of the occurrence of supraventricular arrhythmias (SVAs) is possible only if a surface electrocardiogram (ECG) is recorded during an episode, or if SVAs occur during 24 h ambulatory monitoring (Holter). The automatic interpretation of memory functions in DDD pacemakers may be useful in this diagnostic task over longer periods of follow up. This hypothesis was tested in 384 men and 233 women (mean age = 70 ± 11 years) who had received Chorus 6034/6035, 6234 or 7034 pacemakers (ELA Medical, Montrouge, France) with fall-back function in case of sustained SVAs. The Automatic Interpretation for Diagnostic Assistance (AIDA) algorithm included in these pacemakers was compared with 24 h Holters recorded simultaneously (DI) and with the clinical history of symptoms consistent with SVAs up to 28 days of follow up (D28). Indications for pacing were atrioventricular block (AVB) in 269 patients, sinus node dysfunction (SND) in 248, and AVB + SND in 100. SVAs were documented before implant in 199 patients (32%). Among the 617 patients included at D1. 76 (12.4%) developed at least one SVA episode, lasting between 1 min and 24 hours, simultaneously recorded on Holter and by AIDA with a 93.8% sensitivity and 94.2% specificity. Data from 354 patients were available for analysis at D28. AIDA diagnosed SVAs in 179 patients (50.6%), 104 of whom (65%) had remained asymptomatic and 117 of whom (65%) had had no SVA documented before implant. Among the 354 patients, AIDA diagnosed SVAs in 76 (21%) asymptomatic patients who had no known SVA before implant. The prevalence of SVA in our AVB population was higher than reported in previous studies: 89 patients (56.3%) with AVB had SVAs versus 90 patients (45.9%) with other diagnoses (p=0.55). Furthermore atrial pacing was associated with fewer SVAs. These first clinical results of the AIDA study demonstrate that the memory functions of Chorus pacemakers and the AIDA software are reliable to analyze the prevalence of SVA at 1 month of follow-up. From a clinical point of view, AIDA is a valuable tool to evaluate the efficacy of antiarrhythmic therapy, particularly as it pertains to the prevention of stroke due to atrial fibrillation.     

Implantation of a Carotid Baroreceptor Stimulator in Patients with Pacemakers and Hypertension

Background: The Rheos® System (CVRx, Minneapolis, MN, USA) is an implantable device used to lower blood pressure in patients with resistant hypertension by stimulation of the carotid baroreceptors. It is unknown if interaction might exist between Rheos and conventional pacemakers. Methods: Compatibility of the Rheos device was tested in four patients with preexisting pacemakers. Intra‐ and postoperative testing was completed with pacemaker and Rheos settings programmed to provoke interaction. Intracardiac electrograms were printed to determine interaction with the pacemaker. Results: No interaction was observed at maximum atrial and ventricular sensitivity settings and maximum bilateral Rheos output settings. Conclusion: Concomitant device therapy with Rheos device and pacemakers can be achieved without interaction. (PACE 2011; 34:354–356)     

Efficacy and Safety of Ventricular Rate Responsive Pacing in Children with Complete Atrioventricular Block

Single chamber rate responsive pacing offers many potential advantages over the more complex dual chamber atrial tracking pacing mode in children, and the preservation of atrioventricular synchrony could be unnecessary in selected groups of pediatric patients. Twenty-two pediatric patients (age range 9 months to 12 years; mean 6.5 years) had implantation of ventricular rate responsive (VVIR) pacemakers over a 2-year period. All patients had chronic third-degree atrioventricular block, and a normal ventricular function at rest. During the follow-up each patient underwent a 24-hour Holter monitoring, and ten performed a graded treadmill test in both ventricular fixed rate (VVI) and rate responsive (VVIR) pacing mode. Paced ventricular rates were found to be normal for age in all 22 patients; maximum rate did not reach the higher programmed rate during daily activities in any patient. Comparing the mean paced ventricular rate to the mean rates of blocked P waves, six patients showed a difference of more than 20 beats/min, which induced the pacemaker parameters to be reprogrammed. In all patients a significant correlation was found between variations of paced ventricular rate and variations of spontaneous blocked atrial rhythm (P < 0.05); this correlation persisted in the subsequent Holter controls in the ten patients with longer follow-up. Exercise tolerance resulted normal in the ten patients who performed a treadmill test either in VVIR or VVI mode, with increased maximal heart rates and maximal systolic blood pressure in VVIR mode (P < 0.0013). Rate responsive ventricular pacemakers seem to adequately respond to the physiological needs of daily life of this selected group of children requiring permanent pacing.     

Psychiatric Morbidity and Depressive Symptomatology in Patients with Permanent Pacemakers

Implantation of a permanent pacemaker requires a psychological effort on the patient's part for adaptation in the acute term, and chronically, it restricts activities of the patient and may cause some psychiatric disturbances. To investigate psychiatric morbidity and depressive symptomatology of the patients with permanent pacemakers, 84 pacemaker patients were diagnosed using the DSM-III-R criteria and depressive symptoms were determined by modified Hamilton Depression Rating Scale (mHDRS). Sixteen (19.1 %) patients had been given a psychiatric diagnosis. The most frequent diagnoses were adjustment disorder (5.9%) and major depressive episode (4.7%). Nine patients (10.7%) were diagnosed as having clinical depression (mHDRS ≥ 17). The mean score of mHDRS was 7.57 ± 7.46, and the severity of depression was significantly higher in females. The most frequent symptoms are difficulties in work and activities (53.6%), psychic anxiety (48.8%), loss of energy (42.9%), and hypochondriasis and insomnia (39.3%). Depressed mood, psychic anxiety, loss of energy, loss of interest, insomnia, and hypochondriasis were significantly more frequent in females. Uneducated patients had a more significant loss of energy than educated patients. Depressed mood, psychic anxiety, and somatic concerns and symptoms were more frequent in patients with permanent pacemakers than in the general population. These symptoms, resembling mixed anxiety-depression disorder, were related to fears of having a permanent pacemaker, since our series were composed of uneducated patients who did not have enough knowledge about the device.     

Physiological Versus Single-Rate Ventricular Pacing: A Double-Blind Cross-Over Study

Previous comparisons of physiological and single-rate ventricular pacing are mostly based on open studies. The present investigation was designed to control possible biases of such a study design with the aim to investigate effects of the two pacing modes on maximal and submaximal exercise tolerance and the subjective feeling of well-being of the patients. Forty-four patients treated with atrioventricular synchronous pacemakers for more than 12 months participated in the study. Their pacemakers were randomly programmed to one 3-week long period of ventricular inhibited and a similar period of atrioventricular synchronous ventricular inhibited pacing. Thereafter, they went through echocardiography, symptom-limited maximal exercise test and answered a questionnaire on subjective symptoms. The study was blind since neither the patients nor the physician conducting the exercise tests were informed of pacing mode. The mean maximal exercise tolerance increased 14% (p less than 0.01) on atrioventricular synchronous pacing. Arterial lactate, respiratory rates and perceived exertion ratings during submaximal levels of exercise were higher on ventricular inhibited pacing, as well as symptoms scored during the two 3-week periods. A majority of patients improved their functional class during atrioventricular synchronous pacing and preferred the physiological pacing mode.     

Trends in Pacemakers Which Physiologically Increase Rate: DDD and Rate Responsive

Exercise (rate) responsive pacemakers benefit patients by providing increased cardiac output when needed and permitting lower rate during rest. This paper briefly reviews trends in reported studies on rate responsive pacemakers. For patients with reliable atrial rhythms, atrial-triggered pacemakers (DDD) provide physiological ventricular rates unless complications arise. At low rates, A-V synchrony benefits patients with refractory cardiac decompensation; however, in patients with healthy myocardiums, achieving higher pacing rates is more significant than maintaining synchrony. If atrial rhythms are unreliable, an alternative sensor for determining pacing rate is indicated. Pacemakers that respond to changes in right ventricular blood temperature, respiratory rate, QT interval, body vibration (motion), and pH have been implanted in humans. Clinical evaluations have shown that increased pacing rate leads to increased exercise tolerance and cardiac output when needed, independent of the sensor type (DDD, QT, respiratory rate, etc.). The effectiveness of any sensor type to increase pacing rate appropriately requires reliable sensors that respond specifically to the need for increased pacing rate. Sensors for stroke volume, venous oxygen saturation, right atrial or ventricular pressure and catecholamines are also under preclinical investigation. The availability of a reliable, long-term sensor is a key limitation to several techniques including pH. stroke volume, oxygen saturation, pressure, and catecholamines. Sensor technology and clinical effectiveness are the keys to rate responsive pacing.     

Effects of Extracorporeal Shock Wave Lithotripsy on Cardiac Pacemakers and its Safety in Patients with Implanted Cardiac Pacemakers

Ejects of extracorporeal shockwave lithotripsy (ESWL) were studied on 15 pacemakers (standard single chamber n = 5, dual chamber n = 6, rate responsive single chamber [Activitrax] n = 4). In-vitro testing involved suspending the pacemakers in a bath of degassified, deionized water firmly taped to a platform at the point of maximal pressure, i.e., second focal point (F2), where they received pressure shocks (x?= 1300) from the HM3 Dornier lithotriptor. The pacemakers, programmed to their most sensitive setting, were continuously pacing at nominal outputs (atria) and ventricular pacing in the DDD mode). All units were assessed by a pacing system analyzer before and after the study, then underwent destructive analysis. During standard single chamber pacing (VVI) the pacing stimulus triggered ESWL. For dual chamber devices, ESWL was triggered by the atrial paced event which induced inhibition of the ventricular output in two pacemaker. This was eliminated by reprogramming to a less sensitive setting. The pacemaker can, hermetic seal and internal circuitry were undamaged in all units. Two rate responsive single chamber pacemakers had their activity sensing piezoelectric elements shattered when placed at F2. Two other units placed 5 cm from F2 were stimulated to their maximum upper programmed pacing rate with ESWL therapy, but were otherwise unaffected. Subsequent to this study, six patients with pacemakers programmed to the VVI (five), DDD (one) modes implanted in the thorax underwent successful ESWL without pacemaker or arrhythmic event. Conclusions: (A) It is generally safe for patients implanted with standard single chamber devices in a ventricular application to undergo ESWL without modifying the pacing/sensing parameters. (B) Patients implanted with dual chamber devices who pace in the atrium should be reprogrammed to the VVI mode during ESWL. (C) Patients with piezoelectric activity sensing rate responsive single chamber pacemakers should have this feature programmed off during ESWL and, if implanted in the abdomen, probably should not undergo ESWL.     

Behavior of Different Activity-Based Pacemakers During Treadmill Exercise Testing with Variable Slopes: A Comparison of Three Activity-Based Pacing Systems

A new generation of activity-based pacemakers incorporates an accelerometer sensitive to low frequency acceleration signals in the anteroposterior direction for sensing of bodily stress. The purpose of our investigation was to test a representative model of these new activity-based pacemakers (Relay) and compare it with current vibrationand housing pressure-sensing systems. We tested ten pacemaker patients with implanted Activitrax, Sensolog, and Relay systems during treadmill exercise testing with variable slopes. Devices from the three systems were also strapped externally to the chest of each patient and to ten normal test subjects in the control group. Exercise tests were conducted with changes of treadmill speed and/or treadmill slope. For comparable workloads during constant speed/variable slope and constant slope/variable speed, Relay had similar rate responses (difference not significant). Significant differences (P < 0.05) in rate adaptation attributable to the kind of treadmill exercise (change in treadmill speed or slopes) were observed in the housing pressure- and vibration-based pacemakers. Activity-based pacemakers with an acceleration sensor adapt pacing rates during treadmill exercises independent of treadmill speed or slope better than those controlled by a conventional housing pressure or vibration sensor.